How much does the drug Soliris cost?
How much does the drug Soliris cost?
Priced at $678,392 per year, Soliris is used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome — blood disorders that result in the destruction of red blood cells. The dosing regimen for Soliris can differ depending on the age of the patient and the condition being treated.
Is Soliris the most expensive drug?
At a cost of more than $500,000 per year, Soliris is one of the most expensive drugs in the world. And rightfully so: Not only is it the first of its kind, but it is extremely effective at treating certain rare diseases once thought to be fatal.
Who owns Soliris?
Alexion Pharmaceuticals
| Type | Subsidiary |
|---|---|
| Headquarters | Boston, Massachusetts |
| Key people | Leonard Bell (Chairman) Ludwig N. Hantson (CEO) |
| Products | Eculizumab (Soliris) Ravulizumab (Ultomiris) Asfotase alfa (Strensiq) Sebelipase alfa (Kanuma) Andexanet alfa (Andexxa) |
| Revenue | US$6.069 billion (2020) |
Who is the manufacturer for Soliris?
BOSTON –(BUSINESS WIRE)–Jun. 27, 2019– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration ( FDA ) approved SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
What is the most expensive injection?
The most recent treatment is Zolgensma (generic name onasemnogene abeparvovec), a pioneering gene therapy dubbed “the most expensive drug in the world” and only available through the NHS since March 2021. Zolgensma uses a harmless virus with some of its DNA replaced by a copy of the human SMN1 gene.
When does Soliris patent expire?
Additional patents expire in March 2027. In a recent patent settlement, Alexion have prevented the release of Amgen’s Soliris biosimilar until 1 March 2025. The deal was reached on 28 May 2020 and settles three Inter Partes Review (IPR) proceedings for patents on Soliris.
How much is Alexion worth?
Market cap: $40.33 Billion As of December 2021 Alexion Pharmaceuticals has a market cap of $40.33 Billion.
Why does Soliris cost so much?
A special drug for an extremely rare disease, Soliris costs about half a million dollars per patient, per year, for life. Why? The reasons for the price are locked in “the black box” of drug pricing that governments are seeking to crack open.
What is the most expensive thing known to man?
The most expensive man-made object is the International Space Station (ISS). Its final cost will be over $100 billion (£66.7 billion).